MarshallB.ElamMD
Cardiology • Memphis, TNAdult Congenital Heart Disease
Professor of Pharmacology and Medicine, Director, Lipid Metabolism Clinics, VAMC, University of Tennessee Health Science Center College of Medicine
Dr. Elam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1030 Jefferson Ave
Memphis Va Hypertension/Lipid Research Clinic 111q
Memphis, TN 38104Phone+1 901-523-8990Fax+1 901-448-7206- Is this information wrong?
Education & Training
University of TennesseeFellowship, Cardiovascular Disease, 1982 - 1985- University of TennesseeResidency, Internal Medicine, 1979 - 1982
University of Tennessee Health Science Center College of MedicineClass of 1982
Certifications & Licensure
TN State Medical License 1981 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 1 citationsAtorvastatin-Associated Rhabdomyolysis in a Patient with a Novel Variant of the SLCO1B1 Gene: A Case ReportAjay Venkatanarayan, Mendel Roth, Marshall B. Elam> ;Journal of Clinical Lipidology. 2021 Nov 23
- 12 citationsInsulin-induced de novo lipid synthesis occurs mainly via mTOR-dependent regulation of proteostasis of SREBP-1cQingming Dong, Gipsy Majumdar, Robert N. O'Meally, Robert N. Cole, Marshall B. Elam, Rajendra Raghow> ;Molecular and Cellular Biochemistry. 2020 Jan 1
- 13 citationsSuggested clinical approach for the diagnosis and management of 'statin intolerance' with an emphasis on muscle-related side-effects.Anosh Sivashanmugarajah, Jordan Fulcher, David R. Sullivan, Marshall B. Elam, Alicia J. Jenkins, Anthony C Keech> ;Internal Medicine Journal. 2019 Sep 1
- Join now to see all
Journal Articles
- Trial Designs Rationale and Design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) Study☆Marshall Elam, Aruna D Pradhan, William R Hiatt, ScienceDirect
Grant Support
- Molecular Mechanisms Of Mitigation Of Insulin Induction Of SREBP-1C By N-3 PUFAVeterans Affairs2011–2012
- Regulation Of SREBP-1C Processing By Insulin And Cyclic-AmpNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2010
- Assessment Of Androgenic Hormones In Patients With Coronary Heart DiseaseNational Center For Research Resources1998–2001
- Atherosclerotic Multifactorial Disease Trial--AdmitNational Center For Research Resources1995–1996
Hospital Affiliations
Lt. Col. Luke Weathers, Jr. VA Medical CenterMemphis, Tennessee
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
